Correction: Circulating hsa-miR-221 as a possible diagnostic and prognostic biomarker of diabetic nephropathy

Affiliations

¹ Medical Biochemistry Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt. drmarwasayed2016@gmail.com.
² Internal Medicine Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
³ Clinical and Chemical Pathology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
⁴ Physiology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
⁵ Medical Biochemistry Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.

Published Erratum

Marwa Sayed Abdel-Tawab et al. Mol Biol Rep. 2023.

. 2023 Dec 20;51(1):24.

doi: 10.1007/s11033-023-09085-x.

¹ Medical Biochemistry Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt. drmarwasayed2016@gmail.com.
² Internal Medicine Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
³ Clinical and Chemical Pathology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
⁴ Physiology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
⁵ Medical Biochemistry Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.

No abstract available

Erratum for

Circulating hsa-miR-221 as a possible diagnostic and prognostic biomarker of diabetic nephropathy.
Abdel-Tawab MS, Mohamed MG, Doudar NA, Rateb EE, Reyad HR, Elazeem NAA. Abdel-Tawab MS, et al. Mol Biol Rep. 2023 Dec;50(12):9793-9803. doi: 10.1007/s11033-023-08846-y. Epub 2023 Oct 13. Mol Biol Rep. 2023. PMID: 37831346 Free PMC article.